Host defense against fungal pathogens: Adaptable neutrophil responses and the promise of therapeutic opportunities?
PLoS Pathog
.
2021 Jul 29;17(7):e1009691.
doi: 10.1371/journal.ppat.1009691.
eCollection 2021 Jul.
Authors
Allison K Scherer
1
2
3
,
Alex Hopke
3
4
5
,
David B Sykes
2
3
6
7
,
Daniel Irimia
3
4
5
,
Michael K Mansour
1
2
3
Affiliations
1
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
2
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
3
Harvard Medical School, Boston, Massachusetts, United States of America.
4
Center for Engineering in Medicine and Surgery, Department of Surgery, Harvard Medical School, Boston, Massachusetts, United States of America.
5
Shriners Burns Hospital, Boston, Massachusetts, United States of America.
6
Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
7
Harvard Stem Cell Institute, Cambridge, Massachusetts, United States of America.
PMID:
34324592
PMCID:
PMC8321001
DOI:
10.1371/journal.ppat.1009691
No abstract available
Publication types
Research Support, N.I.H., Extramural
Review
MeSH terms
Animals
Fungi / immunology
Humans
Mycoses / immunology*
Neutrophils / immunology*
Grants and funding
R01 GM092804/GM/NIGMS NIH HHS/United States